机构：[1]Department of Otolaryngology-Head and Neck Surgery, Beijing Tongren Hospital, Capital Medical University, Beijing, China.临床科室耳鼻咽喉-头颈外科首都医科大学附属北京同仁医院首都医科大学附属同仁医院[2]NHC Key Laboratory of Human Disease Comparative Medicine, Beijing Engineering Research Center for Experimental Animal Models of Human Critical Diseases, Institute of Laboratory Animal Sciences, Chinese Academy of Medical Sciences (CAMS) and Comparative Medicine Center, Peking Union Medical College (PUMC), Beijing, China.[3]National Cancer Center/Cancer Hospital, CAMS & PUMC, Beijing, China.[4]Department of Otolaryngology-Head and Neck Surgery, Beijing Tongren Hospital, Capital Medical University, Beijing, China. trchxh@163.com.临床科室耳鼻咽喉-头颈外科首都医科大学附属北京同仁医院首都医科大学附属同仁医院[5]NHC Key Laboratory of Human Disease Comparative Medicine, Beijing Engineering Research Center for Experimental Animal Models of Human Critical Diseases, Institute of Laboratory Animal Sciences, Chinese Academy of Medical Sciences (CAMS) and Comparative Medicine Center, Peking Union Medical College (PUMC), Beijing, China. gaoran@cnilas.org.
Correction to: Cancer Gene Ther https://doi.org/10.1038/s41417-
021-00354-0, published online 22 June 2021
In Fig. 3A, the images of B220 and CD11C in Ogr1−/− group are
the same. After checking with the raw data, we figured out the
picture of CD11C in Ogr1−/− group were incorrectly copied during
the overall picture layout. We have changed the picture and the attachment are the corrected Fig. 3A and Fig. 3.
语种：
外文
PubmedID：
中科院(CAS)分区：
出版当年[2020]版：
大类|2 区医学
小类|2 区生物工程与应用微生物2 区遗传学3 区医学：研究与实验3 区肿瘤学
最新[2025]版：
大类|3 区医学
小类|3 区生物工程与应用微生物3 区遗传学3 区医学：研究与实验4 区肿瘤学
第一作者：
第一作者机构：[1]Department of Otolaryngology-Head and Neck Surgery, Beijing Tongren Hospital, Capital Medical University, Beijing, China.[2]NHC Key Laboratory of Human Disease Comparative Medicine, Beijing Engineering Research Center for Experimental Animal Models of Human Critical Diseases, Institute of Laboratory Animal Sciences, Chinese Academy of Medical Sciences (CAMS) and Comparative Medicine Center, Peking Union Medical College (PUMC), Beijing, China.
通讯作者：
推荐引用方式(GB/T 7714)：
Cao Lin,Li Weisha,Yang Xingjiu,et al.Correction: Inhibition of host Ogr1 enhances effector CD8+ T-cell function by modulating acidic microenvironment.[J].Cancer Gene Therapy.2021,28(10-11):1225-1226.doi:10.1038/s41417-021-00384-8.
APA：
Cao Lin,Li Weisha,Yang Xingjiu,Zhang Wenlong,Li Mengyuan...&Gao Ran.(2021).Correction: Inhibition of host Ogr1 enhances effector CD8+ T-cell function by modulating acidic microenvironment..Cancer Gene Therapy,28,(10-11)
MLA：
Cao Lin,et al."Correction: Inhibition of host Ogr1 enhances effector CD8+ T-cell function by modulating acidic microenvironment.".Cancer Gene Therapy 28..10-11(2021):1225-1226
